Two tRNA methyltransferase mutants, isolated as described in the accompanying paper (G. R. Bjork and K. Kjellin-Striby, J. Bacteriol. 133:499-507, 1978), are biochemically and genetically characterized. tRNA from mutant IB13 lacks 5-methylaminomethyl-2-thio-uridine in vivo due to a permanently nonfunctional methyltransferase. Thus tRNA from this mutant is a specific substrate for the corresponding tRNA methyltransferase in vitro. In spite of this defect in tRNA, such a mutant is viable. Mutant IBll is conditionally defective in the biosynthesis of 1-methylguanosine in tRNA due to a temperature-sensitive tRNA(l-methylguanosine)methyltransferase. In mutant cells grown at a high temperature, the level of 1-methylguanosine in bulk tRNA is 20% of that of the wild type, demonstrating that in this mutant an 80% deficiency of 1-methylguanosine in tRNA is not lethal. Genetically these two distinct lesions, trmC2, causing 5-methylaminomethyl-2-thio-uridine deficiency, and trmDl, giving a temperaturesensitive tRNA(l-methylguanosine)methyltransferase, are both located between 50 and 61 min on the Escherichia coli chromosome.
Only a few mutants with specific defects in tRNA modification are known. In the preceding paper (5), we presented preliminary information on two new mutants, IBll and IB13, that seemed to be methyl deficient in their tRNA since the in vitro methylated RNA was soluble in 2M LiCl. We now show that mutant IBll harbors a temperature-sensitive tRNA(l-methylguanosine)methyltransferase and that mutant IB13 pernanently lacks mam5s2U in its tRNA.
MATERIALS AND METHODS
Abbreviations. Abbreviations used in this paper are those recommended by the Commission on Biochemical Nomenclature (CBN-1970):
Tris, tris(hydroxymethyl)aminomethane; U, uridine; m5U, 5-methyluridine (ribothymidine); Um, 2'-O-methyluridine; mam's2U, 5-methylaminomethyl-2-thio-uridine; C, cytidine; m5C, 5-methylcytidine; Cm, 2'-0-methylcytidine; m'I, 1-methylinosine; G, guanosine; m1G, 1-methylguanosine; m2G, 2-methylguanosine; m7G, 7-methylguanosine; A, adenosine; m2A, 1-methyladenosine; m`A, 6-methyladenosine; Am, 2'-0-methyladenosine; and Gm, 2'-0-methylguanosine. In addition, the tRNA methyltransferase producing 1-methylguanosine is called tRNA(l-methylguanosine)methyltransferase (EC 2.1.1.31), and trm and Trmn designate the genotype and phenotype, respectively, of tRNA methylation-defective mutants.
Bacterial strains, media, and growth conditions. The Escherichia coli K-12 strains used are listed in Table 1 . Growth conditions and media (salt 508 medium E, rich medium LB, and others) are as described in the accompanying paper (5) . In the genetic experiments, the following medium was used: medium E, glucose (0.2%), all amino acids (25 jg/ml), adenine (30 ,ug/ml), guanine (30 fig/ml), uracil (30 jig/ml);
vitamins thiamine (1 ,ug/ml), riboflavine (1 ug/ml), biotine (2.5 ng/ml), nicotinic acid (1 Ag/ml), pantothenic acid (2,ug/ml), inositol (5 ,ug/ml), paraaminobenzoic acid (0.5 itg/ml), pyridoxine (1 ,tg/ml), and folic acid (0.4 ,ug/ml); and streptomycin (100 yg/ml). In vivo labeling. Cells were grown in LB medium containing either L-[methyl-14C]methionine (parental strain; 5 ,uCi/ml of a 56-mCi/mmol solution) or L-[methyl-3H]methionine (mutant strain, 50 1iCi/ml of a 11-Ci/mmol solution). The final specific activity of L-methionine in the medium is not known since unlabeled L-methionine is present in the rich medium used. Cells were grown at different temperatures from 4 x 107 to 6 x 10G cells per ml, harvested, washed once in 10 mM Tris-hydrochloride (pH 8.0)-10 mM magnesium acetate, and total RNA was prepared as described in the accompanying paper. The aqueous phase after the phenol extraction was directly applied to a Sephadex G200 column, operated with 0.05 M triethyl-ammonium acetate buffer (pH 5.2) (9). The fractions containing rRNA (both 23S and 16S RNA) and those containing tRNA and 58 RNA were pooled.
[methyl-14C]tRNA (3 x (20) , and radioactivity of 3H and 14C was determined as described in the accompanying paper (5) . The average of all ratios obtained from one analysis was set to 1.0, and then all normalized ratios were calculated. Thus all experiments can be compared, and when the level of a nucleoside is as in the wild type, the normalized ratio should be 1.0. Preparation of tRNA. The tRNA preparations used for experiments on methyl group incorporation into tRNA in vitro were prepared by the method of Avital and Elson (1) . The celLs were grown in LB-MHU medium (5) and washed with 0.9% NaCl. The method involves phenol extraction in the presence of chloroform, stripping the amino acids (1 h at 370C in 0.5 M Tris, pH 9.7), and fractionation of rRNA and tRNA with 2 M LiCI in 0.1 M potassium acetate (pH 5.0). The tRNA was dialyzed for 22 h against 6 liters of 0.1 mM magnesium acetate. Such tRNA preparations are reported to have a very small amount of high-molecular-weight contaminants (1) , and this has been confirmed by Sephadex G100 molecular sieve chromatography, in which only a very small amount of rRNA was detected.
Methylation of tRNA in vitro. The procedure was essentially as described in reference 6. Conjugation procedures. The conjugation procedure of Miller was used (15 and half of the amount was methylated in vitro in a total volume of 0.2 ml using S-[methyl-"C]adenosyl-L-methionine as methyl donor as described (5) . A partially purified enzyme was used and, therefore, the in vitro methylation reaction was terminated by adding 3 ml of 0.01 M HCl04 containing 0.5 M La(NO3)3. Precipitated RNA was collected on a glass fiber filter and washed twice with 5 ml of 5% trichloroacetic acid and 20 ml of acetone. The 14C/3H ratios for trmC+ and trmC2 recombinants were 0.06 ± 0.04 and 0.4 ± 0.1, respectively. Three independent analyses were run with control strains GB4 and IB1302. Recombinants with '4C/3H ratios higher than twice the 04C/ 3H ratios obtained with the control strain were judged as TrmC-.
Test for TrmJ) phenotype. Recombinants from crosses with strain IB1102 were grown and tested as described for TrmC recombinants, but at a temperature of 43.5°C. 3H-labeled total RNA was prepared, and half the amount was methylated in vitro in a total volume of 0.2 ml. After in vitro methylation, which was catalyzed with a crude enzyme extract as described in the accompanying paper (5), carrier RNA (rRNA, 500 ug, and tRNA, 100 ug) was added, and the in vitro methylated RNA was reisolated by phenol extraction. After precipitation with ethanol, tRNA was extracted from the pellet by 2 M LiCl in 0.05 M ammonium acetate, pH 5.0. tRNA was precipitated with trichloroacetic acid (10% final concentration), collected on a glass fiber filter, and washed as described above. When strain IB11 was the recipient, the purified recombinants were grown overnight at The next day the culture was diluted with 10 ml of the same medium and incubated for 4 to 6 h at 43.5°C. After addition of carrier cells (107 cells), the culture was harvested and cells were washed once with 10 mM Tris-hydrochloride (pH 8.0) containing 0.01 M magnesium acetate. The 3H-labeled RNA was methylated in vitro as described above for IB1102 recombinants.
The 14C/3H ratios for trmD' and trmDl were 0.027 ± 0.002 and 0.11 ± 0.03, respectively. Three independent analyses were run with control strains GB4 and GB5 and mutants IB11 and IB1102. Recombinants with '4C/3H ratios higher than twice the '4C/3H ratios obtained with the control strains were judged as Trm-.
The trmD' recombinants were tested at least twice to ascertain that the genotype was correct.
RESULTS
Methyl group acceptor in IBlI and IB13 is tRNA. When total RNA from mutants IBll and IB13 was methylated in vitro, the label is soluble in 2 M LiCl. This could result from either tRNA being the methyl group acceptor or from an extensive degradation of in vitro labeled rRNA resulting in small components that are LiCl extractable. To discriminate between these two possibilities, strains IBll and IB13 and the parental strain GB5 were grown at 280C in rich medium (LB-MHU) supplemented with [3H]uracil. At 2 x 108 cells per ml, the cultures were shifted to 440C and incubated for 4 h. Total RNA was extracted and methylated with a wild-type enzyme and S-[methyl-'4C]-adenosyl-L-methionine as methyl donor. The 'IC-and 3H-labeled total RNAs were then subjected to polyacrylamide gel electrophoresis ( Fig. 1) . In no case did the rRNA region contain any "4C-labeled methyl groups. As expected, the tRNA from the parental strain was already fully methylated in vivo and did not incorporate any additional methyl groups in vitro (Fig. la) . In both mutants, the methyl group acceptor in vitro was tRNA. Figure 1 polyacrylamide gel containing 0.5% agarose (17) . The gel tube was 19 cm long, and the electrophoresis was performed at 220 V, 2 mA/tube, for 250 min. The gel was sliced in 2-mm sections. The RNA in each slice was hydrolyzed in 0.5 ml of 0.5 M NaOH overnight at 37°C. After neutralization with 0.5 ml of 0.5 M acetic acid, the radioactivity was determined with a scintillation counter. tRNA migrates aroundl fraction 10, 5S rRNA around fraction 17, and rRNA around fraction 67. Fractions 42 to 72 are not shown. Table 2 shows that tRNA from strain IB1102 accepted methyl groups in vitro only when tRNA was isolated from cells grown at 43.500.
The extent was about 10 times higher than that of the control tRNA, corresponding to one methyl group incorporat ininto 5% of the chains.
In IB1302 tRNA, the methyl deficiency was independent of growth temperature, and 3 to 4% of the tRNA chains ared ala able to accept one methyl group each.
Product made in vitro is mpG in IBsl tRNA and mam2s2U in IB13 tRNA. tRNA was prepared from strain IB1102 grown at 43.50C and from strain IB1302 grown at different temperatures. After methylation in vitro using extract from wild-type cells as the enzyme on October 27, 2017 by guest http://jb.asm.org/ Downloaded from source, the methyl-"4C-labeled tRNA was reisolated with phenol extraction and ethanol precipitations. tRNA from IB1102 was enzymatically degraded (5) , and the hydrolysate was subjected to two-dimensional thin-layer chromatography. The positions of radiaoctive compounds were determined by radioautography. The chromatogram shown in Fig. 2 demonstrates that the only product made was m'G. Radioactive IB1102 tRNA was hydrolyzed also with 1 M HCl to purine bases and pyrimidine nucleotides (7) . Two-dimensional thin-layer chromatography of this hydrolysate verified that 1-methylguanine was the only methylated product formed.
tRNA from strain IB1302 grown at different temperatures was methylated in vitro and degraded to nucleosides. When analyzed, three different products were always obtained ( Fig.  3 ): compound 13, now identified as mam5s2U, and compounds 14 and 15 (65, 20, and 10% of the recovered radioactivity [9,000 cpm], respectively). Since strain GM19 (14) is known to be defective in the biosynthesis of mam5s5U, it could be used for comparison. Hydrolysate from in vitro methylated tRNA from GM19 gave the same three products as obtained with tRNA The results of such analyses for the two mutants IB1102 and IB1302 grown at different temperatures are shown in Table 3 as normalized ratios, allowing direct comparisons between the different experiments. Thus at 43.50C, IB1102 tRNA had a m'G level that was only 20% of the normal level (0.12 mol/mol of tRNA), whereas at 280C the level was normal. Compound 5 was the only other spot for which a significant difference was found. Table 3 shows that the only compound affected in mutant IB1302 is mam6s2U (compound 13 in Fig. 4) . At 280C the level of this nucleoside is only 10% of the level found in wild-type tRNA, which agrees mlGr",-l-2nd Two-dimensional thin-layer chromatography of hydrolysate from tRNA originating from strain IB1302 grown at 43.5°C. Before digestion to nucleosides, tRNA was methylated in vitro using enzyme fraction PII, which is an enzyme extract purified through a two-phase system, diethylaminoethyl-cellulose and phosphocellulose chromatography. Dashed areas indicate locations of radiaoctive spots visualized by autoradiography. The same results were obtained with tRNA from cells grown at 28°C. 'This high ratio depends on the unexpected low level (0.07 to 0.14) of Gm found in the wild-type strain GB4. In S. typhimurium, the level of Gm is 0.13 to 0.20 mol/mol of tRNA, which we assume to be the normal level even in E. coli GB5, the parental strain. This strain is temperature sensitive and cannot be used as a reference strain at temperatures above 32°C. f This low ratio depends on isotopic effect, since it was obtained by mixing 3H-CH3-labeled tRNA with 11C-CH3-labeled tRNA, both from wild-type cells. with in vitro data (cf. Table 2 ). mam6s2U and m7G migrate close to each other, and m7G counts can easily contaminate the mam6s2U area considerably (Fig. 4) , especially since m7G in wildtype tRNA is at least 10 times as abundant as is mam5s2U. We therefore believe that contamination with m7G has affected the ratios for mam5s2U at 37 and 43.50C ( Fig. 3 ), and consistently these tRNA preparations all lack mam6s2U in vivo ( Table 3) . The other mutant, IB11, contains a mutated tRNA(1-methylguanosine)methyltransferase, which upon raising the temperature becomes inactivated. At 43.5°C, newly synthe- sized tRNA lacks m'G in vivo (Table 3) and thus constitutes a specific substrate for m'G formation in vitro (Fig. 2) (10, 11, 12, 21) . Aberrant translational suppression in the supK mutants of S. typhimurium is due to an unidentified defect in tRNA methylation (19) . The first description of a bacterial mutant with a specific defect in methyltransferase activity was trmA of E. coli. This mutant lacks m5U in tRNA as a consequence of a mutation in the tRNA(5-methyluridine)-methyltransferase gene (3, 4) . This defect gives the cells inferior survival properties compared to those of wild-type cells (6) . Later, Marinus et al. (14) characterized E. coli mutants with defects in the biosynthesis of m7G (trmB) and of mam's2U (trmC).
One of our strains, IB13, seems to be mutated in the trmC gene. tRNA from both trmC mutants, i.e., IB13 and Marinus' mutant GM19, gave the same products in vitro and both mutations mapped in the same area. We therefore denote our mutation trmC2. In our hands the extent of tRNA methylation from IB13 and GM19 is about 0.04 mol of CH3 per mol of tRNA. Marinus et al. (14) report a level of 0.01 mol of CH3 per mol of tRNA. We believe that this low level of methyl-group acceptance is due to differences in technique and is not biologically significant. When IB13 or GM19 were methylated in vitro, three different products were obtained, but preferentially mam6s2U. With strain GM19, Marinus et al. (14) found only this modified nucleoside. The three products we found were formed when both crude extract and a more purified enzyme fraction (PII, cf. Fig. 2 ) catalyzed the in vitro reaction. The two minor components might be either intermediates in the synthesis of the final product mam5s2U or degradation products of this modified nucleoside. Our attempts to demonstrate that the two minor compounds could be degradation products have so far given only negative results. Although we cannot exclude that the two minor components result from additional mutations, that identical results were obtained with two independent mutants (IB13 and GM19) indicate a relationship between the two minor compounds and mam5s2U.
Strain IB11 is the first mutant isolated with a defect in the biosynthesis of m'G in tRNA.
Furthermore, the mutation that has occurred renders the tRNA(1-methylguanosine)methyltransferase temperature sensitive, which is of technical advantage, and also proves that our new screening method (5) works as predicted.
Of the E. coli tRNA chains hitherto sequenced, only tRNAALeU and tRNA2Leu contain a modified guanosine (8), probably m1G. These tRNA's con-in compound 5 is of the same magnitude as for m1G, whereas at 43.50C the decrease is more pronounced for m'G than for compound 5. Our enzyme extracts from wild-type cells contained activity for formation of compound 5 (cf. Fig.  5 ), but no (i.e., <2% of m'G) such compound was formed with tRNA from IB1102 as substrate. A closer examination of these contradictory results might clarify whether biosyntheses of compound 5 and m1G are interrelated, or whether two independent mutations cause the concominant decrease in the in vivo levels of m'G and compound 5 at higher temperatures.
Mutations like those described in this paper could result in either inactive enzymes, presence of enzyme inhibitors, or changes in the methyl donor level in the cell. Enzyme extract from the mutant IB1302 lacks almost all activity for the production of mam6s2U in vitro, and, furthermore, the extract contains no inhibitor to this activity as tested in mixing experiments (unpublished data). The temperature sensitivity of the tRNA(1-methylguanosine)methyltransferase in vitro strongly indicates that the enzyme itself is structurally changed. Thus, in both strains IB13 and IB11, we believe that the mutations are located in the structural genes for the respective enzymes. Aside from genes trmC and trnD mentioned here, other genes (trnmA, trmnB, and hisT) involved in tRNA modifications have been investigated with respect to map positions (cf. Fig.  7 ). Thus, with the new mutants in tRNA modification now available, a picture is emerging that genes involved in tRNA biosynthesis are scattered all over the E. coli chromosome.
Deficiency of mam6s2U or m1G in tRNA is not lethal to the cell in that genetic background in which they were isolated. Although the mutants have a reduced growth rate compared to that of the parental strain, it is premature to evaluate this as being due to a deficiency in tRNA methylation, since the mutants probably contain additional mutations. A transfer of the trm genes to a known genetic background must be performned before decisive experiments can be made to elucidate the consequences of these mutations for the cell.
